MedPath

CENTRE LEON BERARD

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer

Not Applicable
Conditions
Breast Cancer
First Posted Date
2011-09-26
Last Posted Date
2020-03-24
Lead Sponsor
Centre Leon Berard
Target Recruit Count
40
Registration Number
NCT01440413
Locations
🇫🇷

Centre Leon Berard, LYON Cedex 08, France

🇫🇷

Centre Georges François Leclerc, DIJON Cedex, France

Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck

Phase 3
Completed
Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
First Posted Date
2011-09-01
Last Posted Date
2021-06-01
Lead Sponsor
Centre Leon Berard
Target Recruit Count
134
Registration Number
NCT01427478
Locations
🇫🇷

Centre François Baclesse, Caen, France

🇫🇷

Centre Paul Papin, Angers, France

🇫🇷

CHU Bordeaux - Hôpital Saint-André, Bordeaux, France

and more 23 locations

Evaluation of the Occurrence of Acute Complications Caused by a Central Venous Catheter Placement

Completed
Conditions
Anesthesia
First Posted Date
2011-07-29
Last Posted Date
2014-09-12
Lead Sponsor
Centre Leon Berard
Target Recruit Count
1780
Registration Number
NCT01405534
Locations
🇫🇷

Centre Léon Bérard, LYON Cedex 08, France

Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab

Not Applicable
Completed
Conditions
Metastasis
Colorectal Cancer
Interventions
Biological: Bevacizumab + blood samples
First Posted Date
2011-07-29
Last Posted Date
2015-06-29
Lead Sponsor
Centre Leon Berard
Target Recruit Count
63
Registration Number
NCT01405430
Locations
🇫🇷

Centre Léon Bérard, LYON Cedex 08, France

🇫🇷

Hôpital Privé Jean Mermoz, Lyon, France

Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in Oncology

Not Applicable
Terminated
Conditions
Breast Cancer
Interventions
Other: OSTEOPATHY + conventional analgesic treatments
Other: Conventional analgesic treatments
First Posted Date
2011-07-27
Last Posted Date
2015-06-29
Lead Sponsor
Centre Leon Berard
Target Recruit Count
28
Registration Number
NCT01403168
Locations
🇫🇷

Centre Leon Berard, LYON Cedex 08, France

Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

Phase 2
Completed
Conditions
Metastatic Breast Cancer
Interventions
Drug: placebo
First Posted Date
2011-06-07
Last Posted Date
2015-02-09
Lead Sponsor
Centre Leon Berard
Target Recruit Count
24
Registration Number
NCT01368107
Locations
🇫🇷

Centre Leon Berard, Lyon, France

🇫🇷

Institut Curie, Paris, France

🇫🇷

Institut Gustave Roussy, Villejuif, France

Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive Tract

Not Applicable
Conditions
Carcinoma
Interventions
Device: Oncoral® test
First Posted Date
2011-05-26
Last Posted Date
2012-10-02
Lead Sponsor
Centre Leon Berard
Target Recruit Count
485
Registration Number
NCT01361100
Locations
🇫🇷

CHU Caen Cote de Nacre, Caen, France

🇫🇷

Centre Oscar Lambret, Lille, France

🇫🇷

Centre François Baclesse, Caen, France

and more 5 locations

Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy

Not Applicable
Completed
Conditions
Breast Cancer
Adequate Physical Condition
Interventions
Other: Control arm
Other: Intervention arm
First Posted Date
2011-04-08
Last Posted Date
2014-10-30
Lead Sponsor
Centre Leon Berard
Target Recruit Count
60
Registration Number
NCT01331772
Locations
🇫🇷

Centre Leon Berard, Lyon Cedex 08, France

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Phase 2
Completed
Conditions
GIST
Interventions
Other: Best supportive care
First Posted Date
2011-03-25
Last Posted Date
2016-02-25
Lead Sponsor
Centre Leon Berard
Target Recruit Count
81
Registration Number
NCT01323400
Locations
🇫🇷

Hôpital Tenon, Paris, France

🇫🇷

Centre Oscar Lambret, Lille, France

🇫🇷

Hôpital St Antoine, Paris, France

and more 10 locations

Lidocaine 5% Plasters (Versatis® 5%) in Pediatric Neuropathic Pains and Vasoocclusive Sickle Cell Crisis Pains

Phase 2
Completed
Conditions
Neuropathic Pains
Vasoocclusive Sickle Cell Crises Pains
Interventions
First Posted Date
2011-03-14
Last Posted Date
2014-10-30
Lead Sponsor
Centre Leon Berard
Target Recruit Count
39
Registration Number
NCT01314300
Locations
🇫🇷

Centre Médico-chirurgical de Réadaptation des Massues, Lyon, France

🇫🇷

IHOP, Lyon, France

© Copyright 2025. All Rights Reserved by MedPath